{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:23Z","timestamp":1791596963404,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["956758"],"award-info":[{"award-number":["956758"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117326","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:41:25Z","timestamp":1787625685000},"page":"117326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reducing sialylation in melanoma increases classical pathway-mediated complement activation"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-5321","authenticated-orcid":false,"given":"Magali","family":"Coccimiglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa C.","family":"Toffoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja D.","family":"de Gruijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Chiodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"van Kooyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117326_bib1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.117326_bib2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117326_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110641","article-title":"Sialic acids in cancer biology and immunity-recent advancements","volume":"301","author":"van Vliet","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117326_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.117326_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109037","article-title":"The transcriptional landscape of glycosylation-related genes in cancer","volume":"27","author":"Rodriguez","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.117326_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bjd\/ljad517","article-title":"The sialic acid-Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanoma","volume":"190","author":"Coccimiglio","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.isci.2026.117326_bib7","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.cell.2021.04.023","article-title":"Small RNAs are modified with N-glycans and displayed on the surface of living cells","volume":"184","author":"Flynn","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117326_bib8","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1158\/0008-5472.CAN-17-3376","article-title":"Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity","volume":"78","author":"B\u00fcll","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117326_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101950","article-title":"Complement and the hallmarks of cancer","volume":"78","author":"Artero","year":"2025","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ni.1655","article-title":"Modulation of the antitumor immune response by complement","volume":"9","author":"Markiewski","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117326_bib13","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1038\/s41598-022-09407-2","article-title":"Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway","volume":"12","author":"Shahraz","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117326_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2026.117326_bib15","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","article-title":"Discrimination between activators and nonactivators of the alternative pathway of complement","volume":"87","author":"Meri","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117326_bib16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1523\/JNEUROSCI.3830-11.2012","article-title":"Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia","volume":"32","author":"Linnartz","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.isci.2026.117326_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nchembio.999","article-title":"Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome","volume":"8","author":"Rillahan","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2026.117326_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117326_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1436","article-title":"The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation","volume":"12","author":"de Boer","year":"2023","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/bloodadvances.2018025692","article-title":"Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera","volume":"3","author":"Pouw","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.117326_bib21","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.molimm.2006.01.003","article-title":"Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop","volume":"43","author":"Brouwer","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0161-5890(88)90169-1","article-title":"The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the \u201carms\u201d of C1q","volume":"25","author":"Hoekzema","year":"1988","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib23","article-title":"Tumor sialylation controls effective anti-cancer immunity in breast cancer","author":"Mereiter","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117326_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","article-title":"Siglec-9 Regulates an Effector Memory CD8(+) T-cell Subset That Congregates in the Melanoma Tumor Microenvironment","volume":"7","author":"Haas","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.117326_bib25","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1172\/JCI65899","article-title":"Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance","volume":"124","author":"Jandus","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117326_bib26","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome","volume":"182","author":"Ferreira","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2020-141289","article-title":"Defects in Sialic Acid Biosynthesis Cause Dysregulation of the Alternative Pathway of Complement","volume":"136","author":"Chen","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117326_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2019.00752","article-title":"Complement C5b-9 and cancer: mechanisms of cell damage, cancer counteractions, and approaches for intervention","volume":"10","author":"Fishelson","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41419-017-0240-z","article-title":"Cooperation between Hsp90 and mortalin\/GRP75 in resistance to cell death induced by complement C5b-9","volume":"9","author":"Rozenberg","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117326_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2249.2003.02066.x","article-title":"Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid","volume":"131","author":"Donin","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib31","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4049\/jimmunol.136.7.2534","article-title":"A molecular mechanism of complement resistance of human melanoma cells","volume":"136","author":"Panneerselvam","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4049\/jimmunol.2101196","article-title":"At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity","volume":"209","author":"Oskam","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16541","article-title":"Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2","volume":"32","author":"Budding","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.isci.2026.117326_bib34","series-title":"Natural IgM Antibodies and Immunosurveillance Mechanisms against Epithelial Cancer Cells in Humans","author":"Stephanie Brandlein","year":"2003"},{"key":"10.1016\/j.isci.2026.117326_bib35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/acschembio.6b00173","article-title":"Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes","volume":"11","author":"Li","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.isci.2026.117326_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164230","article-title":"Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients","volume":"11","author":"Pochechueva","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.117326_bib37","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/cbic.201402019","article-title":"Rhamnose glycoconjugates for the recruitment of endogenous anti-carbohydrate antibodies to tumor cells","volume":"15","author":"Sheridan","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.isci.2026.117326_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10517-019-04379-2","article-title":"Analysis of Anti-Glycan IgG and IgM Antibodies in Colorectal Cancer","volume":"166","author":"Tikhonov","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.isci.2026.117326_bib39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1042\/BCJ20200610","article-title":"Anti-glycan antibodies: roles in human disease","volume":"478","author":"Temme","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.117326_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41420-023-01686-6","article-title":"The monosialoganglioside GM1a protects against complement attack","volume":"9","author":"Wedekind","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2026.117326_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10346","article-title":"C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation","volume":"7","author":"Bulla","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117326_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/2326-6066.CIR-13-0173","article-title":"Transient complement inhibition promotes a tumor-specific immune response through the implication of natural killer cells","volume":"2","author":"Janelle","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.117326_bib43","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.4049\/jimmunol.1600210","article-title":"The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses","volume":"196","author":"Nabizadeh","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.immuni.2015.03.009","article-title":"Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response","volume":"42","author":"Surace","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.117326_bib45","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1008363601515","article-title":"Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients","volume":"11","author":"Baars","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.117326_bib46","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.141.5.1602","article-title":"Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies","volume":"141","author":"Hack CE","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117326_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2018.02.004","article-title":"CRISPR\/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research","volume":"456","author":"Thielen","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2026.117326_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s42003-023-04431-y","article-title":"The neoepitope of the complement C5b-9 Membrane Attack Complex is formed by proximity of adjacent ancillary regions of C9","volume":"6","author":"Bayly-Jones","year":"2023","journal-title":"Commun. Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226027045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226027045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:55:52Z","timestamp":1791593752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226027045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226027045"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117326","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing sialylation in melanoma increases classical pathway-mediated complement activation","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117326"}}